AI IntelligenceSep 2, 2026Primary Market
Article
Thyme Care · $125M · Series E
Thyme Care, a virtual cancer treatment navigation platform, closed a $125 million Series E funding round, pushing its post-money valuation above $2 billion. This represents a significant re-rating from its $1 billion+ valuation in 2025.
Data Cube AI EditorialSource: techmeme.com
01
Source Brief
Thyme Care, a virtual cancer treatment navigation platform, closed a $125 million Series E funding round, pushing its post-money valuation above $2 billion. This represents a significant re-rating from its $1 billion+ valuation in 2025.
02